Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine in Advanced Pancreatic Adenocarcinoma
NCT00085371Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triapine in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Jul 2004; status: completed.
02
Drugs
triapine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00085371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085371.